CHAPEL HILL, N.C., Aug. 5 /PRNewswire/ -- Increased market share is the most important success indicator for measuring effectivenessof managed care pull-through programs. However, gauging the Return on Investment for pull-through initiatives is a challenge. For 33 percent of companies, insufficient metrics and analysis is a hurdle for increasing pull-through.
"You have to decide at the beginning what 'good' looks like," explains an interviewed associate director. "If you reach that, you've done a great job. If not, you have to reevaluate to see what's not working and make changes."
Download a complimentary summary of "Managed Care Pull-Through Excellence: From Formulary Access to Increased Market Share" at http://www3.best-in-class.com/rr1015.htm. It includes selected best practices drawn from extensive primary research with executives from 24 leading pharmaceutical companies including, Pfizer, Takeda, GlaxoSmithKline, Daiichi-Sankyo and Boehringer Ingelheim.
The full 85-page report contains more than 250 benchmark metrics and 40 best practices, providing account managers, sales leaders and brand executives a roadmap to identify and close performance gaps in their own pull-through organizations and to improve their processes, programs and activities.
Key topics of this primary research include:
For more information on this study or other recent primary research studies, contact us at 919.403.0251 or at firstname.lastname@example.org.
BEST PRACTICES, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for more than 17 years; our clients include 48 out of the top 50 pharmaceutical companies.
SOURCE Best Practices, LLC
Subscribe to our Free Newsletters!
Nocturnal polyuria refers to increased urine output during night, without an associated increase in ...
Nootropics are drugs or substances which improve cognition that are being increasingly used ...
Pterygium or Surfer's eye is described as a proliferative disorder of the ocular surface possibly ...View All